DMD Trp3X nonsense mutation associated with a founder effect in North American families with mild Becker muscular dystrophy-Reference-Cited by-同舟云学术

DMD Trp3X nonsense mutation associated with a founder effect in North American families with mild Becker muscular dystrophy

Published:2009-11 Issue:11 Volume:19 Page:743-748
ISSN:0960-8966
Container-title:Neuromuscular Disorders
language:en
Short-container-title:Neuromuscular Disorders

Author:

Flanigan Kevin M.,Dunn Diane M.,von Niederhausern Andrew,Howard Michael T.,Mendell Jerry,Connolly Anne,Saunders Carol,Modrcin Ann,Dasouki Majed,Comi Giacomo P.,Del Bo Roberto,Pickart Angela,Jacobson Richard,Finkel Richard,Medne Livija,Weiss Robert B.

Publisher

Elsevier BV

Subject

Genetics(clinical),Clinical Neurology,Neurology,Pediatrics, Perinatology, and Child Health

Reference27 articles.

1. The muscular dystrophies;Emery;Lancet,2002

2. The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. I. Natural history;Bushby;J Neurol,1993

3. Grandpa and I have dystrophinopathy?: approach to asymptomatic hyperCKemia;Saengpattrachai;Pediatr Neurol,2006

4. Mutation spectrum leading to an attenuated phenotype in dystrophinopathies;Tuffery-Giraud;Eur J Hum Genet,2005

5. Protein- and mRNA-based phenotype–genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene;Deburgrave;Hum Mutat,2007

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic counseling for the dystrophinopathies—Practice resource of the National Society of Genetic Counselors;Journal of Genetic Counseling;2024-04-29

2. The complex landscape of DMD mutations: moving towards personalized medicine;Frontiers in Genetics;2024-03-26

3. GNE Myopathy and Duchenne Muscular Dystrophy in Two Moroccans Families;Muscle Ligaments and Tendons Journal;2023-12

4. Persistence of exon 2 skipping and dystrophin expression at 18 months after U7snRNA-mediated therapy in the Dup2 mouse model;Molecular Therapy - Methods & Clinical Development;2023-12

5. Is it time for genetic modifiers to predict prognosis in Duchenne muscular dystrophy?;Nature Reviews Neurology;2023-06-12